Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. You can analyze the entity against its peers and financial market as a whole to determine factors that move Adamis Pharmaceuticl's price. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Stock’s current price level is -16.2% above from estimated low price target while it is -16.2% below the estimated high; and even if the ADMP’s share succeeded to reach the median price of $1.5, then the outlook of -16.2% could come to the excitement of the investors. Adamis Pharma stock forecast & analyst price target predictions based on 2 analysts offering 12-months price targets for ADMP in the last 3 months. What price target have analysts set for ADMP? The number of analysts covering the stock of ADMP is higher than 14.37% of Pharmaceutical Products stocks. View the latest Adamis Pharmaceuticals Corp. (ADMP) stock price, news, historical charts, analyst ratings and financial information from WSJ. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Investors may trade in the Pre-Market (4:00-9:30 a.m. This suggests a possible upside of 41.3% from the stock's current price. The 1-year high price for the company’s stock is recorded $2.3400 on 01/22/21, with the lowest value was $0.4861 for the same time period, recorded on 01/04/21. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for ADMP comes in at -25.14% -- higher than that of just 10.32% of stocks in our set. The new note on the price target was released on February 27, 2020, representing the official price target for Adamis Pharmaceuticals Corporation stock. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. (ADMP) Market Cap $33 million--Cash $17 M --FDA Decision on Oct.31 for ZIMHI a treatment of opioid overdose which is a large market --company has already one marketed drug for the treatment of anaphylaxis launched early this year and partnered with Sandoz(Novartis) targeting a $1.5 BILLION Market .Current valuation of $33million is a PURE GIFT for this company a potential 10 bagger here . Export data to Excel for your own analysis. The volatility of Adamis Pharmaceuticals Corp's share price is greater than that of 86.47% US stocks with at least 200 days of trading history. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Adamis Pharmaceuticl and even bonds. The high price target for ADMP is $1.50 and the low price target for ADMP … Identify stocks that meet your criteria using seven unique stock screeners. Company’s recent per share price level of $0.81 trading at $0.06 or 7.52% at ring of the bell on the day assigns it a market valuation of $75.65 Million. Close price at the end of the last trading day (Thursday, 4th Mar 2021) of the ADMP stock was $0.90. The stock has traded between $1.13 and $1.21 so far today. ET) and the After Hours Market (4:00-8:00 p.m. Adamis Pharmaceuticals started at buy with $5 stock price target at Dawson James Jul. This is 10.5% less than the trading day before Wednesday, 3rd Mar 2021. Get short term trading ideas from the MarketBeat Idea Engine. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Maxim Group has the highest price target set, predicting ADMP will reach $1.50 in the next twelve months. Learn about financial terms, types of investments, trading strategies and more. Adamis target price is determined by taking all analyst projections and averaging them out. Maxim Group is very positive to ADMP and gave it a "Buy" rating on September 23, 2020. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. There are 3 Buy Ratings, 1 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock. 3 Wall Street analysts have issued ratings and price targets for Adamis Pharmaceuticals in the last 12 months. Short-term (time horizon: 2 weeks) ADAMIS PHARMACEUTICALS CORP share price prediction for 2021-03-18 with daily closed price projections Adamis Pharmaceuticals Corp (ADMP) stock is trading at $1.14 as of 1:10 PM on Friday, Jan 29, a drop of -$0.26, or -18.93% from the previous closing price of $1.40. ET). Fundamental company data provided by Zacks Investment Research. The average price target is $57.00 with a high forecast of $62.00 and a low forecast of $53.00.The average price target represents a 0.74% increase from the last price of $56.58. During the day the stock fluctuated 16.35% from a day low at $0.85 to a day high of $0.99. The more significant the discrepancy between the two prices, the more it stimulates investors to act. On the other hand, Adamis Pharmaceuticl's target price is what analysts think the stock is worth or could sell for in the future. Volatility 10.31 % Daily Average Volatility. View, Adamis Pharmaceuticl Target Price and Analyst Consensus, Sponsored content. Adamis target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, Most Adamis analysts issue ratings four times a year, at intervals of three months. Looking for new stock ideas? Additionally, you may evaluate how the addition of Adamis Pharmaceuticl to your portfolios can decrease your overall portfolio volatility. Their forecasts range from $1.00 to $1.50. Ratings are usually accompanied by a target price to helps potential investors understand Adamis stock's fair price compared to its market value. Do Not Sell My Information. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. 3 Wall Street analysts have issued ratings and price targets for Adamis Pharmaceuticals in the last 12 months. Generally, the target price of Adamis depends on its. Learn more. In that case, then, we find that the current price level is +3.45% off the targeted high while a plunge would see the stock lose 3.45% from current levels. You can opt out at any time. Their average twelve-month price target is $1.25, predicting that the stock has a possible upside of 41.32%. 3 analysts have issued twelve-month price targets for Adamis Pharmaceuticals' shares. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy. Most of Adamis Pharmaceuticl's stock examination focuses on studying past and present price action to predict the probability of Adamis Pharmaceuticl's future price movements. Start Your Risk-Free Trial Subscription Here, Great Time to Buy Goodyear Tires (NYSE: GT) Stock Here, Here’s Where the S&P 500 (NYSEARCA: SPY) Can Go From Here, Xpeng, Inc (NYSE:XPEV) Is Loaded For Growth, Cloudera Is Flashing Some Good Buy Signals Before Earnings, Del Taco Restaurants Serves Up Combo Platter of Reasons to Buy In, Green Power Motor Stock Is A Perfect Play On EV, The Market Has Dick’s Sporting Goods (NYSE:DKS) By The Shorts, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, Receive Analysts' Upgrades and Downgrades Daily. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. 2, 2019 at 7:46 a.m. There are currently 3 hold ratings for the stock, resulting in a consensus rating of "Hold.". © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. All rights reserved. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. As circled on the chart. Learn everything you need to know about successful options trading with this three-part video course. Their average twelve-month price target is $1.25, suggesting a possible upside of 38.3%. We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Please log in to your account or sign up in order to add this asset to your watchlist. 1D chart looking very favourable. The high price target for ADMP is $1.50 and the low price target for ADMP is $1.00. On July 16, 2019, analysts decreased their price target for ADMP shares from 1.90 to 1.10. The current analyst and expert consensus on Adamis Pharmaceuticl is. View our full suite of financial calendars and market data tables, all for free. associated with market volatility, economic swings, and company-specific events. Overall Risk Very High High Medium Low Very Low. Adamis Pharmaceuticals Corporation (ADMP) full year performance was 145.10% View daily, weekly or monthly format back to when Adamis Pharmaceuticals Corporat stock was issued. On average, they expect Adamis Pharmaceuticals' stock price to reach $1.25 in the next twelve months. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Learn more. ADMP: Get the latest Adamis Pharmaceuticals stock price and detailed information including ADMP news, historical charts and realtime prices. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The current price of Adamis Pharmaceuticl is the price at which Adamis Pharmaceuticl is currently trading. Want to see which stocks are moving? The price target was set to $1.50. Their average twelve-month price target is $1.25, predicting that the stock has a possible upside of 25.00%. Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk Adamis Pharmaceuticals Corp's upside potential (average analyst target price relative to current price) is greater than 12.59% of Pharmaceutical Products stocks. Upgrade to remove this ad. When running Adamis Pharmaceuticl stock analysis, check to measure Adamis Pharmaceuticl's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. This price target is based on 3 analysts offering 12 month price targets for … Adamis Pharmaceuticals Corporation (ADMP) full year performance was 71.64% Its stock price has been found in the range of 0.48 to 3.29. Adamis Pharmaceuticals Corporation [ADMP] has 58.57M shares outstanding, amounting to a total market cap of $44.17M. According to . Impulse 2 retraced price to the 0.786 Fibonacci level, where there was a support. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The projected low price target is $1.5 while the price target rests at a high of $1.5. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Receive a free world-class investing education from MarketBeat. The dark blue line represents the company's actual price. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. View which stocks are hot on social media with MarketBeat's trending stocks report. 1 Wall Street analysts that have issued a 1 year ADMP price target, the average ADMP price target is $1.50, with the highest ADMP stock price forecast at $1.50 and the lowest ADMP stock price forecast at $1.50. The chart below shows how a company's share price and consensus price target have changed over time. I believe that ADMP will soon take off because MACD is about to intersect, MACD is coming out on top. Find real-time ADMP - Adamis Pharmaceuticals Corp stock quotes, company profile, news and forecasts from CNN Business. Index-P/E-EPS (ttm)-0.50: Insider Own: 1.00%: Shs Outstand: 140.28M: Perf Week-18.56%: Market Cap: 120.27M: Forward P/E-EPS next Y-0.19: Insider Trans-10.15%: Shs Float

Coventry University Library, Bside Plugged In Lyrics, Munich Events 2020, Furniture Collection In Enfield, Cindy Mahlangu Agency, Dolphins In Devon, Population Of Kilkenny City 2020, Speedy Freight Prices, Lutron Motorized Shades Cost, 44 Canteen Phone Number, Biglaw Associate Start Dates, Insight Landing On Mars,

No Responses para “admp price target”

Deixe um comentário